Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 67,500 |
5 mg | 在庫あり | ¥ 166,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
説明 | Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes. |
別名 | GI-262570, GI-2570, GW 262570X, GI 262570, GI262570 |
分子量 | 546.61 |
分子式 | C34H30N2O5 |
CAS No. | 196808-45-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Farglitazar 196808-45-4 DNA Damage/DNA Repair Metabolism PPAR GI-262570 GI-2570 GW 262570X GI 262570 GI262570 Inhibitor inhibitor inhibit